How AI Is Transforming HER Data And Ophthalmic Images To Advance Our Understanding Of Geographic Atrophy

Today, the landscape of RWE has been transformed by advancements in cloud computing and artificial intelligence (AI)-driven analytics. These technologies now enable the development of predictive models based on near-real-time patient activity, which revolutionizes how healthcare professionals and researchers understand and respond to disease progression and treatment efficacy. One of the most compelling examples of this transformation can be seen in the work being done by Verana Health, particularly in tracking the patient journeys of individuals with geographic atrophy (GA). GA is an advanced form of dry age-related macular degeneration (AMD), characterized by the chronic and progressive degeneration of retinal tissue. This leads to the formation of lesions that grow over time, ultimately resulting in permanent loss of visual acuity. In the United States alone, GA affects approximately one million people. Discover how Verana Health is leveraging AI-powered, rules-based natural language processing (NLP) models to enhance RWE for GA.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.